The stable traits of melanoma genetics: an alternate approach to target discovery
about
Checkpoint Inhibitors and Their Application in Breast CancerHuman melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Melanoma NOS1 expression promotes dysfunctional IFN signalingDirect T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.The immune-related role of BRAF in melanoma.IRF5 gene polymorphisms in melanomaAssociation between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population.IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypesImmunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Harnessing the immune system for the treatment of melanoma: current status and future prospects.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.Immune oncology, immune responsiveness and the theory of everything.
P2860
Q26745442-DA97DB8B-3A27-4B47-81E8-7FA75BB2B200Q30274920-9CCB2CBA-8D93-4777-B633-C9A7D7BFEF8AQ30413226-01027CC3-F159-4366-88F2-9B2C19C10EEBQ33750137-644E5676-F069-4B92-B14C-CA091895F953Q35847321-1F6B3680-7884-4591-B998-048D959D3F7DQ36380375-FD4E214D-1EBC-44B9-99CD-A503ECE7F7C2Q36420867-2DF5909F-EE84-464E-821A-58E985372AF0Q37003368-15816470-F9D6-4D8A-9FB0-A42A43F94663Q37059747-026E1AF4-91EF-4B70-908E-E0369EA8F5B9Q37279217-DD4B809A-67AC-4FBB-8F6B-235476D9DEBEQ37707106-72A5750D-7F36-46FB-A4DD-F0737681E253Q38195656-08E76ADB-32D2-4150-9869-608D3589BBB1Q38806243-A0ED8454-5ED3-4B5A-8D12-99EBA655E66EQ38875037-597AE391-071F-47AE-8332-82C162980477Q38885862-9BAA00DC-A5E4-48FF-B0B5-E78978C50117Q38903238-9D0E92F7-8178-4026-93A3-D6B73884FEC7Q43147493-7D2E72BF-B85A-44B0-9BEC-A820F50A8FD7Q55487467-E3CF7A3B-2412-4E5F-AFE2-23833EC2A95F
P2860
The stable traits of melanoma genetics: an alternate approach to target discovery
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The stable traits of melanoma genetics: an alternate approach to target discovery
@ast
The stable traits of melanoma genetics: an alternate approach to target discovery
@en
The stable traits of melanoma genetics: an alternate approach to target discovery
@nl
type
label
The stable traits of melanoma genetics: an alternate approach to target discovery
@ast
The stable traits of melanoma genetics: an alternate approach to target discovery
@en
The stable traits of melanoma genetics: an alternate approach to target discovery
@nl
prefLabel
The stable traits of melanoma genetics: an alternate approach to target discovery
@ast
The stable traits of melanoma genetics: an alternate approach to target discovery
@en
The stable traits of melanoma genetics: an alternate approach to target discovery
@nl
P2093
P2860
P356
P1433
P1476
The stable traits of melanoma genetics: an alternate approach to target discovery
@en
P2093
David F Stroncek
Francesco M Marincola
Jennifer Reinboth
Lorenzo Uccellini
Lotfi Chouchane
Maria Libera Ascierto
Qiuzhen Liu
Sara Tomei
Tara L Spivey
P2860
P356
10.1186/1471-2164-13-156
P407
P577
2012-04-26T00:00:00Z